Salts and polymorphs of a potent antidiabetic compound

Details for Australian Patent Application No. 2004278416 (hide)

Owner Amgen, Inc.

Inventors McGee, Lawrence R.; Kruk, Henry T.; Yang, Bing

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004278416

PCT Pub. Number WO2005/033074

Priority 60/508,470 03.10.03 US

Filing date 4 October 2004

Wipo publication date 14 April 2005

Acceptance publication date 15 April 2010

International Classifications

A61K 31/47 (2006.01) - Quinolines

C07D 215/16 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/20 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

Event Publications

4 May 2006 PCT application entered the National Phase

  PCT publication WO2005/033074 Priority application(s): WO2005/033074

15 April 2010 Application Accepted

  Published as AU-B-2004278416

12 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004278423-Method and apparatus for filling a vessel with particulate matter

2004278414-Spirocyclic heterocyclic derivatives and methods of their use